MESO · Nasdaq, OTC · CIK 0001345099

MESOBLAST LTD

MESOBLAST LTD’s most recent SEC filing in our snapshot is a Form 6-K filed on Oct 16, 2026. In fiscal 2025 (year ended Jun 30, 2025) it reported revenue of $17.2M and net income of -$102.1M, according to its XBRL data on EDGAR. Its EDGAR record lists 3 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2025
$17.2M
Net income, FY2025
-$102.1M
Form 4 filings on record, past 12 months
3

Company overview

Legal name (as filed)
MESOBLAST LTD
Tickers
MESO, MEOBF
SEC Central Index Key (CIK)
0001345099
Business address
MELBOURNE, VICTORIA, Australia
State or country of incorporation
Australia
Fiscal year ends
June 30
SEC filer category
Large accelerated filer
Position in SEC ticker list
#2126 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from MESOBLAST LTD’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$7.4MFY2021$10.2MFY2022$7.5MFY2023$5.9MFY2024$17.2MFY2025
Net income
-$98.8MFY2021-$91.3MFY2022-$81.9MFY2023-$88.0MFY2024-$102.1MFY2025
MESO annual results
ItemFY2021
ended Jun 30, 2021
FY2022
ended Jun 30, 2022
FY2023
ended Jun 30, 2023
FY2024
ended Jun 30, 2024
FY2025
ended Jun 30, 2025
Revenue$7.4M$10.2M$7.5M$5.9M$17.2M
Net income-$98.8M-$91.3M-$81.9M-$88.0M-$102.1M
Diluted EPS-$0.16-$0.13-$0.11-$0.09-$0.08
Total assets$744.7M$662.1M$669.4M$669.2M$784.7M
Cash and equivalents$136.9M$60.4M$71.3M$63.0M$161.6M

XBRL tags used: revenue = Revenue; netIncome = ProfitLoss; assets = Assets; eps = DilutedEarningsLossPerShare; cash = CashAndCashEquivalents. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

MESO latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Aug 27, 202620-FAnnual report of a foreign private issuer· period Jun 30, 2026Document · Index
Oct 16, 20266-KReport of a foreign private issuer· period Oct 16, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about MESOBLAST LTD, by form type:

6-K ×263 ×104 ×320-F ×1
MESO recent filings
FiledFormWhat it isOriginal
Oct 16, 20266-KReport of a foreign private issuer· period Oct 16, 2026Document · Index
Oct 15, 20266-KReport of a foreign private issuer· period Oct 14, 2026Document · Index
Oct 13, 20266-KReport of a foreign private issuer· period Oct 13, 2026Document · Index
Sep 24, 20266-KReport of a foreign private issuer· period Sep 24, 2026Document · Index
Aug 27, 20266-KReport of a foreign private issuer· period Aug 27, 2026Document · Index
Aug 27, 202620-FAnnual report of a foreign private issuer· period Jun 30, 2026Document · Index
Aug 25, 20266-KReport of a foreign private issuer· period Aug 25, 2026Document · Index
Aug 24, 20266-KReport of a foreign private issuer· period Aug 24, 2026Document · Index
Aug 18, 20266-KReport of a foreign private issuer· period Aug 17, 2026Document · Index
Jul 30, 20266-KReport of a foreign private issuer· period Jul 30, 2026Document · Index
Jul 21, 20266-KReport of a foreign private issuer· period Jul 21, 2026Document · Index
Jul 15, 20266-KReport of a foreign private issuer· period Jul 14, 2026Document · Index
Jul 14, 20266-KReport of a foreign private issuer· period Jul 14, 2026Document · Index
Jul 10, 20266-KReport of a foreign private issuer· period Jul 10, 2026Document · Index
Jul 9, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 7, 2026Document · Index
Jul 1, 20266-KReport of a foreign private issuer· period Jul 1, 2026Document · Index
Jun 25, 20266-KReport of a foreign private issuer· period Jun 25, 2026Document · Index
Jun 10, 20266-KReport of a foreign private issuer· period Jun 10, 2026Document · Index
Apr 30, 20266-KReport of a foreign private issuer· period Apr 30, 2026Document · Index
Apr 29, 20266-KReport of a foreign private issuer· period Apr 29, 2026Document · Index
Apr 29, 20263Initial statement of beneficial ownership· period Mar 18, 2026Document · Index
Apr 17, 20266-KReport of a foreign private issuer· period Apr 17, 2026Document · Index
Apr 15, 20266-KReport of a foreign private issuer· period Apr 15, 2026Document · Index
Apr 13, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 9, 2026Document · Index
Apr 10, 20264Statement of changes in beneficial ownership (insider trade)· period Apr 9, 2026Document · Index
Apr 8, 20266-KReport of a foreign private issuer· period Apr 8, 2026Document · Index
Apr 8, 20266-KReport of a foreign private issuer· period Apr 8, 2026Document · Index
Apr 8, 20266-KReport of a foreign private issuer· period Apr 8, 2026Document · Index
Apr 8, 20266-KReport of a foreign private issuer· period Apr 8, 2026Document · Index
Apr 1, 20263Initial statement of beneficial ownership· period Mar 18, 2026Document · Index
Apr 1, 20263Initial statement of beneficial ownership· period Mar 18, 2026Document · Index
Apr 1, 20263Initial statement of beneficial ownership· period Mar 18, 2026Document · Index
Mar 23, 20263INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES· period Mar 18, 2026Document · Index
Mar 23, 20266-KReport of a foreign private issuer· period Mar 23, 2026Document · Index
Mar 18, 20266-KReport of a foreign private issuer· period Mar 18, 2026Document · Index
Mar 18, 20263Initial statement of beneficial ownership· period Mar 18, 2026Document · Index
Mar 18, 20263Initial statement of beneficial ownership· period Mar 18, 2026Document · Index
Mar 18, 20263Initial statement of beneficial ownership· period Mar 18, 2026Document · Index
Mar 18, 20263Initial statement of beneficial ownership· period Mar 18, 2026Document · Index
Mar 18, 20263Initial statement of beneficial ownership· period Mar 18, 2026Document · Index

Insider filing activity

3 Form 4 filings appear in MESOBLAST LTD’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Biological Products, (No Diagnostic Substances)

All 61 companies in Biological Products, (No Diagnostic Substances)

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001345099 and XBRL company facts. MESOBLAST LTD on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.